CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.

Scan to Download iOS&Android APP

Perdagangan PLx Pharma Inc. - PLXP CFD

0.38
34.48%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.05
Biaya inap posisi Long

Long position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
-0.024068%
Biaya inap posisi short

Short position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
0.001846%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 0.58
Open* 0.54
1-Year Change* 42.11%
Day's Range* 0.38 - 0.54
52 wk Range 0.13-4.71
Average Volume (10 days) 216.99K
Average Volume (3 months) 8.18M
Market Cap 3.94M
P/E Ratio -100.00K
Shares Outstanding 29.14M
Revenue 4.54M
EPS -0.99
Dividend (Yield %) N/A
Beta 3.86
Next Earnings Date Mar 21, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Nov 11, 2022 0.38 -0.16 -29.63% 0.54 0.54 0.38
Nov 10, 2022 0.58 -0.02 -3.33% 0.60 0.60 0.57
Nov 9, 2022 0.57 0.00 0.00% 0.57 0.59 0.57
Nov 8, 2022 0.58 -0.02 -3.33% 0.60 0.60 0.57
Nov 7, 2022 0.63 0.07 12.50% 0.56 0.63 0.56
Nov 4, 2022 0.60 -0.01 -1.64% 0.61 0.67 0.56
Nov 3, 2022 0.61 0.03 5.17% 0.58 0.62 0.58
Nov 2, 2022 0.58 0.00 0.00% 0.58 0.61 0.57
Nov 1, 2022 0.58 0.00 0.00% 0.58 0.59 0.57
Oct 31, 2022 0.59 0.00 0.00% 0.59 0.60 0.57
Oct 28, 2022 0.58 0.02 3.57% 0.56 0.60 0.56
Oct 27, 2022 0.56 0.00 0.00% 0.56 0.57 0.56
Oct 26, 2022 0.57 0.03 5.56% 0.54 0.57 0.54
Oct 25, 2022 0.53 -0.02 -3.64% 0.55 0.56 0.52
Oct 24, 2022 0.58 0.00 0.00% 0.58 0.60 0.58
Oct 21, 2022 0.58 0.00 0.00% 0.58 0.60 0.58
Oct 20, 2022 0.58 0.00 0.00% 0.58 0.60 0.58
Oct 19, 2022 0.58 0.01 1.75% 0.57 0.61 0.57
Oct 18, 2022 0.57 -0.02 -3.39% 0.59 0.59 0.55
Oct 17, 2022 0.56 0.03 5.66% 0.53 0.59 0.53

PLx Pharma Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total revenue 8.208 0.03043 0.56546 0.75311 0.77866
Revenue 8.208 0.03043 0.56546 0.75311 0.77866
Total Operating Expense 48.998 13.4895 14.7678 11.7143 16.6265
Selling/General/Admin. Expenses, Total 40.011 9.15057 10.0266 7.7916 10.175
Research & Development 4.182 4.33897 4.74113 3.92267 4.15745
Unusual Expense (Income) 0 2.29405
Operating Income -40.79 -13.4591 -14.2023 -10.9612 -15.8478
Interest Income (Expense), Net Non-Operating -5.335 -1.75154 -6.3001 11.8576 -0.41889
Net Income Before Taxes -46.125 -15.2107 -20.5024 0.89648 -16.2667
Net Income After Taxes -46.125 -15.2107 -20.5024 0.89648 -15.3467
Net Income Before Extra. Items -46.125 -15.2107 -20.5024 0.89648 -15.3467
Net Income -46.125 -15.2107 -20.5024 0.89648 -15.3467
Income Available to Common Excl. Extra. Items -48.65 -16.948 -34.2532 0.89648 -15.3467
Income Available to Common Incl. Extra. Items -48.65 -16.948 -34.2532 0.89648 -15.3467
Diluted Net Income -48.65 -16.948 -34.2532 0.89648 -15.3467
Diluted Weighted Average Shares 23.6505 9.71495 8.91619 8.73322 7.02048
Diluted EPS Excluding Extraordinary Items -2.05704 -1.74452 -3.84169 0.10265 -2.18599
Diluted Normalized EPS -2.05704 -1.74452 -3.84169 0.10265 -1.9736
Total Adjustments to Net Income -2.525 -1.7373 -13.7508
Cost of Revenue, Total 4.805
Gross Profit 3.403
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total revenue 2.083 1.5919 6.6161 0 0
Revenue 2.083 1.5919 6.6161 0 0
Total Operating Expense 20.279 22.4437 16.4779 6.48048 3.59583
Selling/General/Admin. Expenses, Total 18.456 20.8637 11.0132 5.49775 2.63633
Research & Development 0.654 0.68778 1.55199 0.98273 0.9595
Operating Income -18.196 -20.8518 -9.86185 -6.48048 -3.59583
Interest Income (Expense), Net Non-Operating 7.411 24.4142 -11.7807 -10.0239 -7.94468
Net Income Before Taxes -10.785 3.56237 -21.6425 -16.5044 -11.5405
Net Income After Taxes -10.785 3.56237 -21.6425 -16.5044 -11.5405
Net Income Before Extra. Items -10.785 3.56237 -21.6425 -16.5044 -11.5405
Net Income -10.785 3.56237 -21.6425 -16.5044 -11.5405
Total Adjustments to Net Income 0 -0.00004 0 -2.20269 -0.32227
Income Available to Common Excl. Extra. Items -10.785 3.56233 -21.6425 -18.7071 -11.8628
Income Available to Common Incl. Extra. Items -10.785 3.56233 -21.6425 -18.7071 -11.8628
Diluted Net Income -10.785 3.56233 -21.6425 -18.7071 -11.8628
Diluted Weighted Average Shares 27.5392 27.5742 26.9119 23.6382 16.3616
Diluted EPS Excluding Extraordinary Items -0.39162 0.12919 -0.8042 -0.79139 -0.72504
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.39162 0.12919 -0.8042 -0.79139 -0.72504
Cost of Revenue, Total 1.169 0.89226 3.91274
Gross Profit 0.914 0.69964 2.70336
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 73.476 22.9855 14.2833 14.8654 25.69
Cash and Short Term Investments 69.392 22.4487 14.0013 14.2503 24.4044
Cash & Equivalents 69.392 22.4487 14.0013 14.2503 24.4044
Total Receivables, Net 0.634 0 0.01868 0.01823 0.01938
Accounts Receivable - Trade, Net 0.634 0 0.01868 0.01823 0.01938
Total Inventory 2.458 0.14338 0 0.24637
Prepaid Expenses 0.992 0.39347 0.26327 0.40937 0.30017
Other Current Assets, Total 0 0.18754 0.71967
Total Assets 76.642 26.6166 18.5028 18.3884 28.8486
Property/Plant/Equipment, Total - Net 1.088 1.55304 2.0848 1.39423 1.02988
Goodwill, Net 2.061 2.06102 2.06102 2.06102 2.06102
Intangibles, Net
Other Long Term Assets, Total 0.017 0.01704 0.07367 0.06771 0.06771
Total Current Liabilities 11.879 3.54231 6.09343 4.73266 1.81569
Payable/Accrued 10.6 0.86257 0.92892 0.65305 0.85216
Accrued Expenses 1.278 2.02327 1.50639 1.1699 0.96354
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 24.962 16.1636 16.9331 11.9441 24.2322
Total Long Term Debt 0 0 0.62227 4.28039 6.94215
Other Liabilities, Total 13.083 12.6213 10.2174 2.93104 15.4743
Total Equity 51.68 10.453 1.56962 6.44429 4.61639
Common Stock 0.028 0.01391 0.00916 0.00874 0.00872
Additional Paid-In Capital 183.912 91.203 74.8371 72.8713 71.9399
Retained Earnings (Accumulated Deficit) -148.274 -102.149 -86.9382 -66.4358 -67.3323
Total Liabilities & Shareholders’ Equity 76.642 26.6166 18.5028 18.3884 28.8486
Total Common Shares Outstanding 27.5392 13.9116 9.15626 8.74395 8.72282
Property/Plant/Equipment, Total - Gross 1.553 2.00154 2.52769 1.68631 1.479
Accumulated Depreciation, Total -0.465 -0.4485 -0.44288 -0.29208 -0.44912
Long Term Debt 0 0.62227 4.28039 6.94215
Current Port. of LT Debt/Capital Leases 0 0.62227 3.65812 2.90971
Preferred Stock - Non Redeemable, Net 16.014 21.3849 13.6616
Other Current Liabilities, Total 0.001 0.03421
Total Preferred Shares Outstanding 0.01501 0.023
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 57.748 73.476 88.6142 82.013 84.8674
Cash and Short Term Investments 52.499 69.392 82.5543 80.1695 84.4235
Cash & Equivalents 52.499 69.392 82.5543 80.1695 84.4235
Total Inventory 3.839 2.458 2.19035 1.26248 0.14338
Prepaid Expenses 0.712 0.992 0.61625 0.58101 0.30056
Total Assets 60.858 76.642 91.8361 85.3085 88.3209
Property/Plant/Equipment, Total - Net 1.032 1.088 1.14378 1.21751 1.37546
Goodwill, Net 2.061 2.061 2.06102 2.06102 2.06102
Other Long Term Assets, Total 0.017 0.017 0.01704 0.01704 0.01704
Total Current Liabilities 13.23 11.879 7.40538 3.06477 1.40919
Payable/Accrued 12.716 10.6 6.45217 2.38232 0.96261
Accrued Expenses 0.51113 1.278 0.95321 0.64824 0.41238
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 0 0 0
Other Current Liabilities, Total 0.00287 0.001 0.03421 0.03421
Total Liabilities 18.875 24.962 44.9288 29.1794 22.2751
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 5.645 13.083 37.5234 26.1146 20.8659
Total Equity 41.983 51.68 46.9073 56.1292 66.0459
Preferred Stock - Non Redeemable, Net 16.014 16.014 16.0136 16.0136 21.3849
Common Stock 0.028 0.028 0.02748 0.02615 0.02284
Additional Paid-In Capital 185 183.912 182.702 170.283 158.327
Retained Earnings (Accumulated Deficit) -159.059 -148.274 -151.836 -130.194 -113.689
Total Liabilities & Shareholders’ Equity 60.858 76.642 91.8361 85.3085 88.3209
Total Common Shares Outstanding 27.5392 27.5392 27.477 26.145 22.8363
Total Preferred Shares Outstanding 0.01501 0.01501 0.01501 0.01501 0.023
Total Receivables, Net 0.698 0.634 3.25331
Accounts Receivable - Trade, Net 0.698 0.634 3.25331
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line -46.125 -15.2107 -20.5024 0.89648 -15.3467
Cash From Operating Activities -32.118 -12.2436 -12.659 -9.49923 -13.3066
Cash From Operating Activities 0.116 0.12462 0.15825 0.20096 0.02984
Deferred Taxes 0 -0.92
Non-Cash Items 8.38 3.04205 6.8139 -10.8456 4.91663
Cash Taxes Paid 0 0 0 0 0
Cash Interest Paid 0.006 0.21286 0.6003 0.67115 0.19594
Changes in Working Capital 5.511 -0.19961 0.8712 0.24895 -1.9863
Cash From Investing Activities 0.095 -0.102 -0.23029 -0.65487 11.2389
Capital Expenditures 0 -0.102 -0.24174 -0.65487 -0.53757
Other Investing Cash Flow Items, Total 0.095 0.01144 0 11.7764
Cash From Financing Activities 78.966 20.7929 12.6404 0 26.4127
Issuance (Retirement) of Stock, Net 79.591 24.5429 15.7654 0 23.8444
Issuance (Retirement) of Debt, Net -0.625 -3.75 -3.125 0 2.5683
Net Change in Cash 46.943 8.44735 -0.24896 -10.1541 24.345
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -10.785 -46.125 -49.6874 -28.0449 -11.5405
Cash From Operating Activities -16.893 -32.118 -18.7567 -9.75913 -4.28206
Cash From Operating Activities 0.03 0.116 0.08574 0.05554 0.02656
Non-Cash Items -6.32 8.38 31.7794 19.2826 8.61713
Cash Taxes Paid 0 0 0 0 0
Cash Interest Paid 0 0.006 0.00649 0.00649 0.60195
Changes in Working Capital 0.182 5.511 -0.93438 -1.05234 -1.38523
Cash From Investing Activities 0.095 0.09454 0.04524 0
Capital Expenditures 0 0 0
Cash From Financing Activities 0 78.966 78.7678 67.4347 66.2569
Issuance (Retirement) of Stock, Net 0 79.591 79.3928 68.0597 66.8819
Issuance (Retirement) of Debt, Net 0 -0.625 -0.625 -0.625 -0.625
Net Change in Cash -16.893 46.943 60.1057 57.7208 61.9748
Other Investing Cash Flow Items, Total 0.095 0.09454 0.04524
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Level One Partners LLC Corporation 9.5157 2772643 1452337 2021-12-31
White Rock Capital Management, L.P. Hedge Fund 7.4574 2172900 852594 2021-12-31
Park West Asset Management LLC Hedge Fund 5.0561 1473218 0 2022-12-31 MED
Hardie Robert D Individual Investor 4.0223 1172000 297000 2021-12-31
Green Square Capital Advisors, LLC Investment Advisor 3.3874 987000 794000 2022-12-31 LOW
Valentino (Michael J) Individual Investor 1.6978 494690 0 2022-09-19 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.4013 408320 733 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.1618 338522 -777284 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.8151 237491 -13361 2022-12-31 LOW
Ground Swell Capital, LLC Investment Advisor 0.751 218820 176311 2022-12-31 HIGH
Jane Street Capital, L.L.C. Research Firm 0.6607 192504 192504 2022-12-31 HIGH
Morgan Stanley Smith Barney LLC Investment Advisor 0.6513 189785 -44319 2022-12-31 LOW
University of Texas Investment Management Company Endowment Fund 0.4302 125346 0 2022-12-31 LOW
HRT Financial LP Investment Advisor 0.2984 86942 86942 2022-12-31 HIGH
UBS Financial Services, Inc. Investment Advisor 0.2873 83723 27752 2022-12-31 LOW
Two Sigma Investments, LP Hedge Fund 0.2835 82604 -179302 2022-12-31 HIGH
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.2716 79132 0 2022-12-31 LOW
Virtu Americas LLC Research Firm 0.2449 71368 71368 2022-12-31 HIGH
Ergoteles Capital Hedge Fund 0.2086 60771 60771 2022-12-31 HIGH
Renaissance Technologies LLC Hedge Fund 0.187 54500 54500 2022-12-31 HIGH

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group

500K+

Trader

92K+

Klien aktif per bulan

$53M+

Volume investasi per bulan

$30M+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Industry: Pharmaceuticals (NEC)

9 Fishers Ln Ste E
07871-2402

Income Statement

  • Annual
  • Quarterly

People also watch

BTC/USD

28,226.35 Price
+0.470% 1D Chg, %
Biaya inap posisi Long -0.0616%
Biaya inap posisi short 0.0137%
Waktu biaya inap 21:00 (UTC)
Spread 60.00

Gold

1,960.55 Price
-0.820% 1D Chg, %
Biaya inap posisi Long -0.0173%
Biaya inap posisi short 0.0090%
Waktu biaya inap 21:00 (UTC)
Spread 0.30

US100

12,648.40 Price
+0.550% 1D Chg, %
Biaya inap posisi Long -0.0241%
Biaya inap posisi short 0.0018%
Waktu biaya inap 21:00 (UTC)
Spread 1.8

Oil - Crude

68.60 Price
+1.560% 1D Chg, %
Biaya inap posisi Long -0.0219%
Biaya inap posisi short 0.0000%
Waktu biaya inap 21:00 (UTC)
Spread 0.03

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda